Welcome to Medications.com
 

Best plans go astray at Sanofi - Newark Star Ledger

Spek said Sanofi could lose $1 billion in revenue this year from the sleep aid Ambien MR to generic competition. Teva Pharmaceutical Industries launched ...

http://www.nj.com/business/ledger... | Posted: Sat May 05 21:50:50 +0000 2007


© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea